Position in AZN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$6,015,694
-$241,110 QoQ
Shares Held
31,725
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#370
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Plato Investment Management Ltd holds $101,936,919 across 10 Drug Manufacturers - General names. AZN ranks #8 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,772 | $24,914,562 | |
| 2 | JNJ |
Johnson & Johnson
|
72,416 | $18,391,491 | |
| 3 | ABBV |
AbbVie Inc.
|
61,586 | $15,497,501 | |
| 4 | MRK |
Merck & Co., Inc.
|
74,299 | $9,547,421 | |
| 5 | AMGN |
Amgen Inc
|
22,412 | $8,115,833 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
50,583 | $6,390,656 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
106,571 | $6,140,621 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
31,725 | $6,015,694 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,015,694 | 31,725 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $6,256,804 | 31,725 | Shares | Sole | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||